Prostate cancer (PCa) is a common medical condition in the United States, with an estimated 16% of men receiving a diagnosis during their lifetime. Although it is the second leading cause of cancer-specific deaths among men, PCa will not be the cause of death for most men who are diagnosed with it. Although there are notable improvements recently, the relative dearth of high-quality data concerning PCa screening and treatment in older men calls for a thoughtful approach to evaluating such men for screening, diagnosis, and treatment options. This article offers guidance to an approach here.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Clinics in geriatric medicine. 2015 Aug 25 [Epub]
Breton Roussel, Gregory M Ouellet, Supriya G Mohile, William Dale
Robert Wood Johnson Medical School, Rutgers University, 125 Paterson Street, New Brunswick, NJ 08901, USA. , Department of Medicine, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06510, USA. , Division of Hematology/Oncology, Department of Medicine, Wilmot Cancer Institute, University of Rochester, 601 Elmwood Avenue, Box 704, Rochester, NY 14642, USA. , Section of Geriatrics and Palliative Medicine, Department of Medicine, Specialized Oncology Care & Research in the Elderly (SOCARE) Clinic, University of Chicago, 5841 South Maryland Avenue, MC6098, Chicago, IL 60643, USA. Electronic address: wdale@medicine. bsd. uchicago. edu.